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Abstract 
Clusterin (Apolipoprotein 3, complement lysis inhibitor) is a widely expressed multifunctional glycoprotein. The expression of 
clusterin mRNA has been reported to be elevated in a broad spectrum of apoptotic or degenerative tissues. More recently, it was shown 
that within these tissues clusterin is expressed in the surviving rather than in the dying cells, and that clusterin gene expression is actually 
down-regulated in the apoptotic ells. We have studied the expression of the clusterin gene in apoptotic MDCK cells. Cell death was 
initiated by three different stimuli: application of the steroid hormone antagonist RU 486, activation of protein kinase C by the application 
of the phorbol ester TPA, and - since clusterin is involved in lipid and cholesterol transport - perturbation of cell membranes by 
cholesterol. We show that clusterin gene expression is repressed in cells undergoing apoptosis in response to the application of RU 486 
and TPA, but is unchanged in cells in which apoptosis has been triggered by cholesterol treatment. 
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Clusterin is a heterodimeric glycoprotein found in virtu- 
ally all body fluids and on the surface of cells lining body 
cavities [1]. In serum, it has been characterized as a 
complement lysis inhibitor [2] and as a component of the 
HDL-fraction named apolipoprotein J [3]. We have charac- 
terized the protein (designated gp80) as a marker for 
constitutive secretion at the apical surface of polarized 
epithelial cells [4-7]. In the male reproductive tract, the 
protein has been isolated on the basis of its cell-aggregat- 
ing activity in vitro (hence the name clusterin), and its 
enhanced expression in the regressing prostate after castra- 
tion [8,9]. In the central nervous ystem, expression of the 
protein has also been associated with degenerative pro- 
cesses such as retroviral infection, malignant ransforma- 
tion, epilepsy and M. Alzheimer [1]. On the basis of its 
elevated expression in apoptotic tissues, it was originally 
proposed that the protein might be causally involved in 
apoptosis [1]. More recently, however, evidence is accumu- 
lating suggesting that clusterin expression is not enhanced, 
Abbreviations: MDCK, Madin--Darby canine kidney; FCS, fetal calf 
serum; TPA, 12-O-tetradecanoylphorbol-13-acetate; gp 80, canine clus- 
terin. 
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but rather down-regulated in the cells undergoing apopto- 
sis, and that its expression in the apoptotic tissue is 
restricted to the surviving bystander cells [10,11]. This led 
to the proposal that, rather than being a cell-death gene, 
clusterin is a cell survival gene exerting a protective role 
on the vital neighbouring cells [10-12]. In particular, 
French et al. observed that clusterin gene expression in 
leukocytes and carcinoma cell lines undergoing apoptosis 
triggered by UV irradiation, dexamethasone administration 
or ageing resulted in a marked decrease or absence of 
clusterin gene expression in the dying cells independently 
of the stimulus used [10,11]. Here, we study clusterin gene 
expression during apoptosis in differentiated epithelial 
cells. We show that, in the Canine kidney derived epithelial 
cell line MDCK, clusterin gene expression is either re- 
pressed or unchanged epending upon the stimulus used to 
trigger apoptosis. 
Three different stimuli were used to induce apoptosis in 
MDCK cells: RU 486 triggered steroid hormone depletion, 
TPA induced protein kinase C stimulation [18] and choles- 
terol mediated perturbance of cellular membrane integrity. 
The withdrawal of steroid hormones has been shown to 
lead to apoptosis and to enhanced clusterin expression in 
several systems [1]. In order to investigate apoptosis trig- 
gered by interference with steroid hormone mediated sig- 
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Fig. 1. Analysis of the genomic DNA in apoptotic MDCK cells. 1 : DNA 
size marker (SPP1-DNA, EcoRI digested, obtained from Boehringer 
Mannheim, Germany). 2: DNA extracted from untreated cells; 3: UV- 
irradiated MDCK ceils (positive control); 4: MDCK cells treated with 
5 X 10 -7 M RU486; 5: MDCK cells after TPA-treatment. 
nal transduction, we used the ant i -hormone RU 486 (kindly 
provided by K. StiSckemann, Schering, Berlin), which 
antagonizes both progesterone- and glucocort icoid action. 
Both hormones have been shown to negatively regulate 
clusterin expression in MDCK cells (Flach et al., submit- 
ted). In tumor cells it was shown that antiprogestins may 
Fig. 2. Northern blot analysis of clusterin (gp 80) mRNA after treatment 
of MDCK cells with RU 486. A: MDCK cells were grown to confluency 
and incubated with 5 × 10 -7 M RU486 in serum-free medium (lane RU) 
or in serum-free medium (lane sf). The upper panel shows hybridization 
with clusterin (gp 80) cDNA, the lower panel with a fl-actin probe. 
18S 
Fig. 3. MDCK cells were grown to confluency and incubated inserum-free 
medium with or without TPA. A: Untreated MDCK cells. B: MDCK cells 
treated with TPA (40 ng/ml) for 12 h. C: Northern blot analysis of 
clusterin mRNA in MDCK cells treated with TPA. lane sf: RNA from 
MDCK cells incubated in serum-free medium for 24 h; lane TPA: RNA 
from MDCK cells incubated with TPA (40 ng/ml) for 24 h. The upper 
panel shows the hybridization with clusterin (gp 80) cDNA, the lower 
panel represents he control hybridization with 18S rRNA to show the 
integrity of the RNA. 
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initiate terminal differentiation leading to apoptosis and 
may cause an accumulation of cells in G0G 1 phase of the 
cell cycle [13]. MDCK cells were grown to confluency in 
medium containing 5% FCS, washed thoroughly and incu- 
bated in serum-free medium without or with 5 X 10 -7 M 
RU 486 for 24 h. After the incubation period, a dye 
exclusion test (with Trypan blue, purchased from Merck, 
Darmstadt, Germany) revealed a high proportion of dead 
cells which were predominantly found in the medium. 
While the dye exclusion test does not differentiate between 
apoptotic and necrotic processes, distinct morphological 
and biochemical changes characteristic of apoptosis have 
been described [14]. These include the compaction and 
segregation of chromatin into sharply delineated masses, 
followed by nuclear fragmentation a d the convolution of 
the cell surface before membrane breakdown and cell 
disintegration. The most obvious biochemical event in 
apoptosis is the fragmentation of the genomic DNA into 
multimers of 185 bp due to double-strand cleavages at the 
linker regions between the nucleosomes. These fragments 
are easily detected as a characteristic ladder of bands in 
agarose gel electrophoresis [14]. To detect apoptosis, chro- 
mosomal DNA from RU 486 treated cells was analysed. 
Whereas in control cells no degradation of DNA was 
detected, in RU 486-treated cells a fragment ladder of 
approx. 180 bp steps typical for the endogenous pro- 
grammed cell death associated endonuclease activation 
was observed (Fig. 1). From these cells total RNA was 
isolated and subjected to Northern blot analysis [15]. As 
shown in Fig. 2A, the amount of clusterin mRNA is 
significantly decreased compared to the clusterin mRNA 
level of cells cultivated in serum-free medium for 24 h. To 
exclude the possibility that the observed ecline in clus- 
terin mRNA results from cellular RNA degradation and to 
show specifity of regulation, the same blots were subjected 
to hybridization with a fl-actin probe (created by PCR 
using oligonucleotides obtained from Stratagene, Heidel- 
berg, Germany). 
In order to investigate whether clusterin repression dur- 
ing apoptosis is dependent on the mechanism used to 
initiate apoptosis, we analysed the effect of pertubation of 
another signal transduction pathway to initiate apoptosis in 
MDCK cells. Activation of protein kinase C by phorbol 
ester leads to an enhanced transcription of the oncogenes 
c-jun and c-fos which are able to regulate the transcription 
of genes containing AP-1 binding sites. Although the 
canine clusterin gene has not been sequenced, sequence 
analysis of the human, rat and mouse clusterin genes 
revealed several AP-1 binding sites, leading to the pro- 
posal that this heterodimeric transcription factor plays a 
key role in clusterin gene regulation [16]. Cells were 
grown to confluency, washed thoroughly and incubated 
without or with TPA (40 ng/ml) in serum-free medium 
for 24 h. Upon this treatment, he cells changed their 
morphology within the first 6 h (Fig. 3A and Fig. 3B), 
presumably due to the enhanced expression of c-jun and 
c-fos [17]. Longer incubation in the presence of TPA led to 
significant cell death (as shown by the dye exclusion test). 
Chromosomal DNA was isolated from cells incubated for 
12 h in the presence of TPA and subjected to gel elec- 
trophoresis. This analysis revealed the intranucleosomal 
fragmentation f the DNA characteristic of apoptotic ells 
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Fig. 4. A: analysis of the genomic DNA in cholesterol-treated, apoptotic MDCK cells. MDCK cells were incubated with 10 -4 M cholesterol for 48 h. 
DNA was isolated and subjected to gel electrophoresis (lane 1). Lane S represents a DNA length standard as indicated. B: Northern blot analysis of 
clusterin (gp80) gene expression after treatment of MDCK cells with cholesterol. MDCK cells were incubated in serum-free medium (lane sf) or with 10 -4 
M cholesterol for 24 h (lane 1) o1 48 h (lane 2). The upper panel shows hybridization with clusterin (gp 80) cDNA, the lower panel with a 18S rRNA 
probe. 
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(Fig. 1). Total RNA was extracted from these cells and 
used for Northern blot analysis. Integrity of the RNA was 
demonstrated by hybridization with an 18S rRNA probe 
(kindly provided by P. Ekblom, University Uppsala, Swe- 
den). As seen in Fig. 3C, incubation with TPA led to a 
marked decrease of the clusterin mRNA level. 
In the last approach, a physical insult was used to 
trigger apoptosis in MDCK cells. Clusterin (Apolipo- 
protein J) is thought o be involved in cholesterol transport 
by high density lipoproteins in serum and in the removal 
of cell debris and membrane fragments in apoptotic tis- 
sues, thereby playing an essential role in the maintenance 
of membrane integrity. These ideas prompted us to analyse 
clusterin gene expression in cells in which apoptosis had 
been triggered using perturbation of membrane integrity 
with cholesterol (Sigma, Heidelberg, Germany). MDCK 
cells were cultivated in the presence of 10 -4 M cholesterol 
for 24 or 48 h. Incubation in the presence of cholesterol 
initiated apoptosis in MDCK cells, as demonstrated by the 
characteristic pattern of DNA fragmentation (Fig. 4). The 
analysis of clusterin mRNA level revealed no decrease 
under these conditions, rather a slight but reproducable 
increase in clusterin mRNA level was detected (Fig. 4). 
Together these results demonstrated that, depending upon 
the apoptosis-triggering stimulus, distinct patterns of clus- 
terin gene expression were observed. 
Our results on clusterin gene expression in apoptotic 
MDCK cells are in accordance with the data published by 
French and co-workers who used UV irradiation, in vitro 
ageing and dexamethasone tr atment to trigger apoptosis 
in human myeloid, lymphoid and epithelial cells [ 10,11 ]. In 
no instance did they observe an enhanced clusterin expres- 
sion. The data now available on the expression of clusterin 
in normal and in apoptotic ells and tissues plainly rule out 
the earlier proposal that clusterin gene expression is causal 
to cell death [12,19]. In contrast to the results of French et 
al., who pointed out that independent of the apoptotic 
stimulus clusterin gene expression is repressed, our data 
show that, at least in MDCK cells, modulation of clusterin 
gene expression is dependent upon the stimulus used to 
trigger apoptosis. While it is repressed in cells undergoing 
apoptosis in response to steroid hormone withdrawal or 
protein kinase C induction, it is unchanged in apoptotic 
cells in response to cholesterol-induced membrane distur- 
bance. Thus repression of clusterin gene expression is not 
an obligatory response to apoptosis. Our data suggest hat 
apoptosis, which has been defined by the ordered and 
imperative occurrence of distinct biochemical nd morpho- 
logical events (such as the endonucleolytic breakdown of 
the chromosomal DNA into oligonucleosomes, condensa- 
tion of nuclear chromatin, fragmentation of the nucleus, 
convolution of cell membranes, fragmentation f the cells 
into apoptotic bodies and phagocytosis by macrophages 
and neighboring cells), is not as rigidly fixed a program as 
has been anticipated, but that there might be diversity in 
the cellular esponse to apoptosis. 
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